Weatherstone Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Weatherstone Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,650	Closed	-$234K	–	88
2016 Q2	$234K	Hold	4,650	–	–	0.2%	76
2016 Q1	$249K	Hold	4,650	–	–	0.18%	68
2015 Q4	$305K	Hold	4,650	–	–	0.35%	53
2015 Q3	$263K	Hold	4,650	–	–	0.24%	46
2015 Q2	$275K	Hold	4,650	–	–	0.24%	57
2015 Q1	$291K	Hold	4,650	–	–	0.18%	60
2014 Q4	$265K	Hold	4,650	–	–	0.15%	59
2014 Q3	$249K	Hold	4,650	–	–	0.13%	51
2014 Q2	$244K	Sell	4,650 -20	-0.4%	-$1.02K	0.06%	67
2014 Q1	$231K	Buy	+4,670	New	+$216K	0.07%	55

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Weatherstone Capital Management's TEVA Position: Q3 2016 in Review

Weatherstone Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2016, closing a stake of 4,650 shares — an estimated $234K sold.

Weatherstone Capital Management first reported a position in TEVA in Q1 2014 and held it in 10 quarters. The position peaked at $305K in Q4 2015. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Weatherstone Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2016 after selling out during the quarter.
Weatherstone Capital Management sold 4,650 Teva Pharmaceutical Industries Limited shares in Q3 2016, an estimated $234K.
Weatherstone Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and held it in 10 quarters.
Weatherstone Capital Management's Teva Pharmaceutical Industries Limited position peaked at $305K in Q4 2015.
798 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2016.

Based on Weatherstone Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.